238
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Isolation and structural elucidation of a new tadalafil analogue in health supplements: bisprenortadalafil

, , , , , & show all
Pages 945-952 | Received 23 Mar 2016, Accepted 08 Apr 2016, Published online: 17 May 2016
 

ABSTRACT

A new tadalafil analogue was found, along with nortadalafil, using HPLC-DAD during the inspection of a health product sold without official approval. The analogue was separated using a semi-preparative HPLC system and its structure was determined by a combination of mass spectrometry and NMR spectroscopy. The compound was identified as a tadalafil analogue in which the N-methyl group of tadalafil was replaced with a tadalafil precursor moiety. Nuclear Overhauser effect spectroscopy experiments suggested a cis-relationship between the substituents on a piperidine ring in the tadalafil moiety.

Graphical Abstract

Acknowledgements

Ji Hyun Lee and Han Na Park contributed equally to this paper.

Disclosure statement

No potential conflict of interest was reported by the authors.

Supplemental data

Supplemental data for this article can be accessed here.

Additional information

Funding

This research was supported by research grants [numbers 13181MFDS521 and 15182MFDS523] from the Ministry of Food and Drug Safety (MFDS), Korea, and by a 2015 research grant from Kangwon National University. The authors thank the Central Laboratory of Kangwon National University for providing them with technical assistance for the spectroscopic experiments.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.